Oliguric phase of acute renal failure

Active Ingredient: Mannitol

Indication for Mannitol

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible oliguric renal failure becomes established.

For this indication, competent medicine agencies globally authorize below treatments:

50-200 g/day

Route of admnistration


Defined daily dose

50 - 200 g

Dosage regimen

From 50 To 200 g once every day

Detailed description

Acute renal failure

The general dose range for adults is 50 to 200 g mannitol (330 to 1320 ml) in a 24-hour period, with a dosage limit of 50 g mannitol (330 ml) on any one occasion. In most instances adequate response will be achieved at a dosage of 50 to 100 g mannitol/day (330 to 660 ml). The rate of administration is usually adjusted to maintain a urine flow of at least 30-50 ml per hour.

Only in emergency situations, the maximum infusion rate can be as high as 200 mg/kg infused over 5 minutes (see also test dose). After 5 minutes, the infusion rate should be readjusted to maintain a urine flow of at least 30-50 ml per hour, with a maximum dose of 200 g/24h.

Use in patients with oliguria or renal impairment

Patients with marked oliguria or suspected inadequate renal function should first receive a test dose of approximately 200 mg mannitol/kg bw (body weight) (1.3 ml/kg) infused over a period of 3 to 5 minutes. For example in an adult patient with a body weight of 70 kg: approximately 100 ml of a 15% solution. The response to the test dose is considered adequate if at least 30-50 ml/hour of urine is excreted for 2-3 hours. If an adequate response is not attained, a further test dose may be given. If an adequate response to the second test dose is not attained, treatment with mannitol should be discontinued and the patient reassessed as established renal failure may be present.

Dosage considerations

This hypertonic solution should be administered via a large peripheral or, preferably, a central vein. Rapid infusion in peripheral veins may be harmful.

Active ingredient


Mannitol is a naturally occurring sugar alcohol used clinically primarily for its osmotic diuretic properties.

Read more about Mannitol

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.